DNAM-1/Tigit/CD155/CD112 Axis Is a Novel Target of NK-Cell Therapy in Acute Myeloid Leukemia

被引:2
|
作者
Kaito, Yuta [1 ]
Sugimoto, Emi [2 ]
Nakamura, Fumi [3 ]
Tsukune, Yutaka [4 ]
Sasaki, Makoto [5 ]
Yui, Shunsuke [6 ]
Yamaguchi, Hiroki [6 ]
Goyama, Susumu [7 ]
Nannya, Yasuhito [1 ]
Mitani, Kinuko [3 ]
Tamura, Hideto [8 ]
Imai, Yoichi [3 ]
机构
[1] Univ Tokyo, IMSUT Hosp, Dept Hematol Oncol, Tokyo, Japan
[2] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Tokyo, Japan
[3] Dokkyo Med Univ, Dept Hematol & Oncol, Shimotsuga Dist, Tochigi, Japan
[4] Juntendo Univ, Sch Med, Dept Hematol, Tokyo, Japan
[5] Juntendo Univ, Sch Med, Div Hematol, Tokyo, Japan
[6] Nippon Med Sch, Dept Hematol, Tokyo, Japan
[7] Univ Tokyo, Grad Sch Frontier Sci, Div Mol Oncol, Tokyo, Japan
[8] Dokkyo Med Univ, Saitama Med Ctr, Dept Hematol, Koshigaya, Japan
关键词
D O I
10.1182/blood-2022-164435
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:4514 / 4516
页数:3
相关论文
共 50 条
  • [21] DNAM-1/CD226 is functionally expressed on acute myeloid leukemia (AML) cells and is associated with favorable prognosis
    Chashchina, Anna
    Maerklin, Melanie
    Hinterleitner, Clemens
    Salih, Helmut R.
    Heitmann, Jonas S.
    Klimovich, Boris
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [22] CD155-Tigit Pathway Modulation in Dendritic Cell/Acute Myeloid Leukemia Fusion Vaccine Model
    Nahas, Myrna
    Stroopinsky, Dina
    Capelletti, Marzia
    Rosenblatt, Jacalyn
    Orr, Shira
    Ghiasuddin, Haider
    Morin, Adam
    Liegel, Jessica
    Kufe, Donald
    Avigan, David E.
    BLOOD, 2019, 134
  • [23] Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells
    Grauwet, Korneel
    Cantoni, Claudia
    Parodi, Monica
    De Maria, Andrea
    Devriendt, Bert
    Pende, Daniela
    Moretta, Lorenzo
    Vitale, Massimo
    Favoreel, Herman W.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (45) : 16118 - 16123
  • [24] Impaired DNAM-1/CD155 interaction in MS disrupts NK-mediated immune regulation of T-cell activity and is reconstituted by therapeutic modulation of the IL-2 receptor
    Gross, C. C.
    Schulte-Mecklenbeck, A.
    Ruenzi, A.
    Kuhlmann, T.
    Posevitz-Fejfar, A.
    Schwab, N.
    Schneider-Hohendorf, T.
    Held, K.
    Konjevic, M.
    Dornmair, K.
    Hohlfeld, R.
    Elkins, J.
    Ziemssen, T.
    Meuth, S. G.
    Wiendl, H.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 803 - 804
  • [25] Monitoring TIGIT/DNAM-1 and PVR/PVRL2 Immune Checkpoint Expression Levels in Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
    Hattori, Norimichi
    Kawaguchi, Yukiko
    Sasaki, Yohei
    Shimada, Shotaro
    Murai, So
    Abe, Maasa
    Baba, Yuta
    Watanuki, Megumi
    Fujiwara, Shun
    Arai, Nana
    Kabasawa, Nobuyuki
    Tsukamoto, Hiroyuki
    Uto, Yui
    Yanagisawa, Kouji
    Saito, Bungo
    Harada, Hiroshi
    Nakamaki, Tsuyoshi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (05) : 861 - 867
  • [26] CD84: A Novel Target for CAR T-Cell Therapy for Acute Myeloid Leukemia
    Perez-Amill, Lorena
    Armand-Ugon, Mercedes
    Pena, Sergio
    Casals, Maria Val
    Santos, Claudio
    Frigola, Gerard
    Minguela, Alfredo
    Torralba, Alex Bataller
    Casanovas, Berta
    Alamo, Jose
    Uribe, Mireia
    Sanchez-Martinez, Diego
    Tirado, Nestor
    Bueno, Clara
    Romecin, Paola Alejandra
    Menendez, Pablo
    Martinez, Antonio
    Rovira, Montserrat
    Esteve, Jordi
    Urbano-Ispizua, Alvaro
    Delgado, Julio
    Juan, Manel
    Klein-Gonzalez, Nela
    BLOOD, 2022, 140 : 7379 - 7381
  • [27] THE TIGIT/CD226/CD155 AXIS AND THE EFFECTS OF COMBINING PD-1/PD-L1 BLOCKADE WITH TIGIT-TARGETING ANTIBODY THERAPY IN SYNGENEIC MURINE GLIOBLASTOMA MODELS
    Gokhale, Prafulla
    Iorgulescu, Bryan
    Klapholz, Max
    Poitras, Michael
    Eschle, Benjamin
    Freeman, Gordon
    Anderson, Ana
    Reardon, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A277 - A278
  • [28] NK cells play a significant role in immunosurveillance at the early stage of MLL-AF9 acute myeloid leukemia via CD226/CD155 interactions
    Wang YaJie
    Chen Chen
    Dong Fang
    Ma ShiHui
    Xu Jing
    Gong YueMin
    Cheng Hui
    Zhou Yuan
    Cheng Tao
    Hao Sha
    SCIENCE CHINA-LIFE SCIENCES, 2015, 58 (12) : 1288 - 1298
  • [29] NK cells play a significant role in immunosurveillance at the early stage of MLL-AF9 acute myeloid leukemia via CD226/CD155 interactions
    WANG YaJie
    CHEN Chen
    DONG Fang
    MA ShiHui
    XU Jing
    GONG YueMin
    CHENG Hui
    ZHOU Yuan
    CHENG Tao
    HAO Sha
    Science China(Life Sciences), 2015, (12) : 1288 - 1298
  • [30] NK cells play a significant role in immunosurveillance at the early stage of MLL-AF9 acute myeloid leukemia via CD226/CD155 interactions
    YaJie Wang
    Chen Chen
    Fang Dong
    ShiHui Ma
    Jing Xu
    YueMin Gong
    Hui Cheng
    Yuan Zhou
    Tao Cheng
    Sha Hao
    Science China Life Sciences, 2015, 58 : 1288 - 1298